Solid-lipid nanoparticles (SLNs) are an innovative group of nanosystems used to deliver
medicine to their respective targets with better efficiency and bioavailability in contrast to …

Cutaneous leishmaniasis (CL) and mucocutaneous leishmaniasis (ML) show clinical
spectra that can range from a localized lesion (with a spontaneous healing process) to …

In this work, we developed a solid lipid nanoparticle (SLN) formulation with (+)-limonene 1, 2-
epoxide and glycerol monostearate (Lim-SLNs), stabilized with Poloxamer® 188 in aqueous …

Throughout history, humanity has been threatened by countless epidemic and pandemic
outbreaks of infectious diseases, from the Justinianic Plague to the Spanish flu to COVID …

Background: Biodegradable polymeric nanoparticles have garnered pharmaceutical
industry attention throughout the past decade. PLGA [Poly (lactic-co-glycolic acid)] is an …

The use of lipids in the composition of polymeric-based films for topical administration of
bioactive ingredients is a recent research topic; while few products are commercially …

Cutaneous fungal infections are the fourth most common health problem, which involves
approximately one billion people worldwide. Drug delivery to the skin seems to be the best …

There is a growing clinical demand for topical itraconazole (ITC) delivery systems because
of the expanding potential of the drug for topical fungal and non-fungal applications. Lipid …

Local anesthetics (LAs) are drugs that promote the reversible blocking of neural
transmission by inhibiting the excitation conduction process in peripheral nerves. Tetracaine …

Dermatomycosis is a common fungal infection, and its treatment is limited by few antifungal
agents. Clioquinol (CQ) is an antiparasitic agent that has been studied for new uses, such as …